Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

1
Dolby Laboratories Partners with Wanying Cinema Line to Extend the Spectacular Dolby Cinema Experience in China

7h globenewswire
SAN FRANCISCO and SHENZHEN, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Dolby Laboratories, Inc. (NYSE: DLB) and Wanying Cinema Line (Shenzhen) Company Limited, the high-end cinema exhibitor wholly owned by China Resources Land Limited with the brand MIXCINE, today announced a partnership to extend the spectacular Dolby Cinema® experience to more moviegoers in China. With the partnership, the first location is expected to be open at Wanying’s flagship site in Shenzhen with more locations to come in Southeast China in the following two years.
CRBJY 1109 CRBJF DLB

0
Don't Believe Stocks Always Beat Bonds? Read This

2018-08-16 seekingalpha
The confusion is understandable. And to average investors who are looking to restructure their investments or simply mobilize some cash they have lying around, it's a topic worth shedding light on.
CRBJY 1109 CRBJF

0
Hong Kong shares end higher as property stocks gain

2018-08-07 theedgemarkets
(Aug 7): Hong Kong's main Hang Seng index ended firmer on Tuesday, led by gains in property stocks, after developer Country Garden said it expected upbeat first-half results. The Hang Seng China Enterprises index closed higher.
CRBJY 2313 WHGRF 1109 CRBJF 2007 SZHIF HUNGF HNP 0902 WHGLY WGHPY

0
China stocks rebound, developers lift HK, but trade war fears linger

2018-08-07 theedgemarkets
SHANGHAI (Aug 7): China stocks rose on Tuesday as investors snapped up shares hit by recent heavy losses, but an escalating Sino-US trade war and worries over the prospect for domestic growth are likely to continue to dampen sentiment.
CRBJY WHGRF 1109 CRBJF 2007 HUNGF HNP 0902 WHGLY CRRRF WGHPY

1
China stocks fall on tariff woes, weak data

2018-08-01 thehindubusinessline
At 03:32 GMT, the Shanghai Composite index was down 9.07 points or 0.32 per cent at 2,867.33.
CRBJY WHGRF 1109 CRBJF 2007 AAPL HUNGF HNP 0902 WHGLY WGHPY

0
Hong Kong stocks slammed as investors dump Chinese financials amid trade war anxieties

2018-07-03 scmp
The Shanghai Composite Index drops further after sliding to a 28-month low; the yuan falls to the weakest since last August
CRBJY CICHY 506186 1109 CRBJF GLXYENT CICHF CCB 1088 0939

4
Hong Kong stocks fall to lowest in nearly two weeks as interest rate rise hits property firms

2018-06-14 scmp
Hong Kong’s stock market closed at near a two-week low on Thursday after the city’s de facto central bank raised the cost of borrowing, with property stocks among the losers, while mainland Chinese stocks touched a one-year intra-day low after economic data for May came in weaker than expected.
CRBJY ANPDF 2331 AACAF 1368 ANPDY WHGRF 1109 CRBJF 2007 XTPEF 0700 XTEPY SNCHY WHGLY AACAY WGHPY

1
Property stocks climb after China’s central bank slightly eases monetary policy

2018-06-04 scmp
Shares of Chinese property firms climbed on Monday after the People’s Bank of China (PBOC) said it would broaden the range of collateral it accepts as part of its medium-term lending facility (MLF), making another slight tweak to its monetary policy.
CRBJY 1109 CRBJF 2007 TRI SNCHY

0
Mortgage users say new home sales discrimination is rife, as more developers demand upfront payments

2018-04-10 scmp
Price controls have resulted in new homes being sold at 20-30pc discounts, which has had the knock-on effect that developers are reluctant to sell
CRBJY 1109 CRBJF

0
China, Hong Kong stocks rise as developers rally on stellar profits

2018-03-21 thehindubusinessline
Stocks in China and Hong Kong rallied on Wednesday, led by real estate firms, after developers posted stellar profits for 2017.
CRBJY 1336 1109 CRBJF 2007

0
Chinese developers report strong profits but credit curbs could spell trouble

2018-03-20 scmp
Mainland property developers have posted strong earnings for 2017, but liquidity remains a concern as Beijing keeps a tight lid on financing to cool the housing market.
CRBJY SOHOF 0410 1109 CRBJF

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...